RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
GEN3h
Broken String Biosciences Launches INDUCE-seq Catalyst Program
The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.
Twist Bioscience CEO Emily Leproust sells $256,630 in company stock
CEO Emily Leproust recently sold a portion of her holdings in the company, according to a filing with the Securities and Exchange Commission. The sale, which took place on February 3, 2025, involved 5 ...
Mutations in two gene pairs point to a promising drug target in 5% of adult cancers
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...
Armed robbery in Revesby18h
RAD51 Biomarker Boosts Precision in Prostate Cancer Care
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...
PharmiWeb18h
Liquid Biopsy Market Set for Rapid Growth USD 10,9…
Liquid Biopsy MarketThe global liquid biopsy market is poised for substantial expansion, with an estimated revenue of USD 1,538.3 million in 2023. The market is projected to grow at an impressive ...